These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2664071)

  • 1. Psychopharmacology and Alzheimer's disease.
    Serby M
    J Adv Med Surg Nurs; 1989 Mar; 1(2):32-9. PubMed ID: 2664071
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of treatment-associated changes in behavior and cholinergic therapy of neuropsychiatric symptoms in Alzheimer's disease.
    Cummings JL; Masterman DL
    J Clin Psychiatry; 1998; 59 Suppl 13():23-30. PubMed ID: 9771827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: cognitive and behavioral pharmacotherapy.
    Cummings JL; Mendez MF
    Conn Med; 1997 Sep; 61(9):543-52. PubMed ID: 9334509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Geriatric psychopharmacology. Management of late-life depression and the noncognitive behavioral disturbances of Alzheimer's disease.
    Raskind MA
    Psychiatr Clin North Am; 1993 Dec; 16(4):815-27. PubMed ID: 7906030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacology of Alzheimer's disease.
    Procter AW
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):191-4. PubMed ID: 8777499
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy of Alzheimer's disease].
    Sulkava R
    Duodecim; 2000; 116(24):2867-73. PubMed ID: 12077892
    [No Abstract]   [Full Text] [Related]  

  • 7. [Challenging pharmacotherapy in dementia].
    Ihl R
    MMW Fortschr Med; 2009 Mar; 151(13):46-8. PubMed ID: 19504818
    [No Abstract]   [Full Text] [Related]  

  • 8. Alzheimer's drugs deliver fringe benefits. Cholinesterase inhibitors improve more than just memory.
    Auerbach SH
    Health News; 2003 Mar; 9(3):1-2. PubMed ID: 12703432
    [No Abstract]   [Full Text] [Related]  

  • 9. Pioglitazone improved cognition in a pilot study on patients with Alzheimer's disease and mild cognitive impairment with diabetes mellitus.
    Hanyu H; Sato T; Kiuchi A; Sakurai H; Iwamoto T
    J Am Geriatr Soc; 2009 Jan; 57(1):177-9. PubMed ID: 19170800
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of music therapy on anxiety and depression in patients with Alzheimer's type dementia: randomised, controlled study.
    Guétin S; Portet F; Picot MC; Pommié C; Messaoudi M; Djabelkir L; Olsen AL; Cano MM; Lecourt E; Touchon J
    Dement Geriatr Cogn Disord; 2009; 28(1):36-46. PubMed ID: 19628939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrine for Alzheimer's disease.
    Med Lett Drugs Ther; 1993 Sep; 35(905):87-8. PubMed ID: 8361451
    [No Abstract]   [Full Text] [Related]  

  • 12. Medications to modify at-home behavior of Alzheimer's patients.
    Maletta GJ
    Geriatrics; 1985 Dec; 40(12):31-6, 39-40, 42. PubMed ID: 2866147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alzheimer's disease].
    Pettenati C
    Recenti Prog Med; 1999 May; 90(5):267-70. PubMed ID: 10380555
    [No Abstract]   [Full Text] [Related]  

  • 14. Is antidepressant treatment associated with reduced cognitive decline in Alzheimer's disease?
    Mossello E; Boncinelli M; Caleri V; Cavallini MC; Palermo E; Di Bari M; Tilli S; Sarcone E; Simoni D; Biagini CA; Masotti G; Marchionni N
    Dement Geriatr Cogn Disord; 2008; 25(4):372-9. PubMed ID: 18354253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Concomitant therapies in the clinical trial in Alzheimer's disease].
    Bermejo F; Ferrari JM
    Rev Neurol; 1995; 23(119):118-24. PubMed ID: 8548604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive disinhibition and socioemotional functioning in Alzheimer's disease.
    Nash S; Henry JD; McDonald S; Martin I; Brodaty H; Peek-O'Leary MA
    J Int Neuropsychol Soc; 2007 Nov; 13(6):1060-4. PubMed ID: 17942023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoxetine in dementia of the Alzheimer's type: prominent adverse effects and failure to improve cognition.
    Geldmacher DS; Waldman AJ; Doty L; Heilman KM
    J Clin Psychiatry; 1994 Apr; 55(4):161. PubMed ID: 8071261
    [No Abstract]   [Full Text] [Related]  

  • 18. Beyond symptomatic therapy: a re-examination of acetylcholinesterase inhibitors in Alzheimer's disease.
    Relkin NR
    Expert Rev Neurother; 2007 Jun; 7(6):735-48. PubMed ID: 17561789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment.
    Crook T
    Psychopharmacol Bull; 1988; 24(1):31-8. PubMed ID: 3290945
    [No Abstract]   [Full Text] [Related]  

  • 20. New therapeutic approaches to Alzheimer's disease.
    Schneider LS
    J Clin Psychiatry; 1996; 57 Suppl 14():30-6. PubMed ID: 9024334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.